Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Triple -Negative Breast Cancer · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Breast Tumor Center, Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
Contact: Study coordinator (Jieqiong Liu) · liujieqiong01@163.com · 086-13922272706

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Advanced Solid Tumor · Advanced Malignant Neoplasm · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Irvine, United States · La Jolla, United States

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Triple Negative Breast Cancer · Breast Cancer · Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Phoenix, United States · Orange, United States

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

Metastatic Breast Cancer · Breast Cancer · Breast Cancer Stage IV

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States

TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence

Breast Cancer

Abroad (travel likely)Recruiting

London, Canada · Ottawa, Canada